Tentamus Pharma UK Limited
(PresseBox) ( Derby, UK, )
Food & Drug Analytical Services Limited (FDAS) has changed its name to Tentamus Pharma UK Limited.  This change marks five years following the successful acquisition by Tentamus Group GmbH. The new name better reflects the services and reflects the close relationship of the global Tentamus laboratory network.

The Tentamus Group operates a worldwide network of laboratory businesses. Since acquisition of FDAS in 2016 the group have supported the FDAS management team. Investment has continued in the UK and our local pharmaceutical service offering has developed and grown.

The company will continue to operate in its current structure and will continue with the commitment and core values of providing an exceptional partnership laboratory with a team of dedicated and knowledgeable industry experts.

Larissa Taylor, Technical Director of Tentamus Pharma UK said “Food & Drug Analytical Services described our start-up.  After 17 years of business now is the right time to re-launch our brand.  Through this change we will engage with a larger audience and deliver growth, stability and confidence for our loyal employees and customers. The change is part of a wider integration process of our UK pharmaceutical service.”

About Tentamus Pharma UK Limited

Tentamus Pharma UK Limited is a leading provider of GMP Quality Control Testing.  Providing analytical testing services to pharmaceutical manufacturers, medical device manufacturers, raw material suppliers and Contract Research Organisations from their laboratories in Nottingham.  Expert and dedicated staff deliver accurate, consistent and comprehensive solutions to support the pharmaceutical supply chain.

For further information please visit 

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to